HRP20110024T1 - Antibakterijski derivati kvinolina - Google Patents
Antibakterijski derivati kvinolina Download PDFInfo
- Publication number
- HRP20110024T1 HRP20110024T1 HR20110024T HRP20110024T HRP20110024T1 HR P20110024 T1 HRP20110024 T1 HR P20110024T1 HR 20110024 T HR20110024 T HR 20110024T HR P20110024 T HRP20110024 T HR P20110024T HR P20110024 T1 HRP20110024 T1 HR P20110024T1
- Authority
- HR
- Croatia
- Prior art keywords
- alkyl
- aryl
- het
- mono
- compound according
- Prior art date
Links
- 125000002943 quinolinyl group Chemical class N1=C(C=CC2=CC=CC=C12)* 0.000 title claims 2
- 230000000844 anti-bacterial effect Effects 0.000 title 1
- 229940027991 antiseptic and disinfectant quinoline derivative Drugs 0.000 title 1
- -1 cyano, formyl Chemical group 0.000 claims abstract 68
- 150000001875 compounds Chemical class 0.000 claims abstract 42
- 125000000217 alkyl group Chemical group 0.000 claims abstract 38
- 125000003118 aryl group Chemical group 0.000 claims abstract 29
- 125000001424 substituent group Chemical group 0.000 claims abstract 26
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract 19
- 239000001257 hydrogen Substances 0.000 claims abstract 19
- 125000003710 aryl alkyl group Chemical group 0.000 claims abstract 18
- 125000001475 halogen functional group Chemical group 0.000 claims abstract 18
- 125000003545 alkoxy group Chemical group 0.000 claims abstract 15
- 125000003386 piperidinyl group Chemical group 0.000 claims abstract 15
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract 14
- 125000004433 nitrogen atom Chemical group N* 0.000 claims abstract 14
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims abstract 13
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract 12
- 125000004414 alkyl thio group Chemical group 0.000 claims abstract 10
- 125000001188 haloalkyl group Chemical group 0.000 claims abstract 10
- 125000005984 hexahydro-1H-1,4-diazepinyl group Chemical group 0.000 claims abstract 9
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims abstract 9
- 125000004076 pyridyl group Chemical group 0.000 claims abstract 9
- 125000000714 pyrimidinyl group Chemical group 0.000 claims abstract 9
- 125000004663 dialkyl amino group Chemical group 0.000 claims abstract 8
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims abstract 8
- 125000006350 alkyl thio alkyl group Chemical group 0.000 claims abstract 7
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims abstract 7
- 125000005943 1,2,3,6-tetrahydropyridyl group Chemical group 0.000 claims abstract 6
- 125000004448 alkyl carbonyl group Chemical group 0.000 claims abstract 6
- 125000002393 azetidinyl group Chemical group 0.000 claims abstract 6
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims abstract 5
- 125000004985 dialkyl amino alkyl group Chemical group 0.000 claims abstract 5
- 125000004193 piperazinyl group Chemical group 0.000 claims abstract 5
- 125000004103 aminoalkyl group Chemical group 0.000 claims abstract 4
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims abstract 3
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims abstract 3
- 125000002883 imidazolyl group Chemical group 0.000 claims abstract 3
- 125000003373 pyrazinyl group Chemical group 0.000 claims abstract 3
- 125000003226 pyrazolyl group Chemical group 0.000 claims abstract 3
- 125000002098 pyridazinyl group Chemical group 0.000 claims abstract 3
- 125000000168 pyrrolyl group Chemical group 0.000 claims abstract 3
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims abstract 2
- 125000005094 alkyl carbonyl amino alkyl group Chemical group 0.000 claims abstract 2
- 125000005418 aryl aryl group Chemical group 0.000 claims abstract 2
- 125000005129 aryl carbonyl group Chemical group 0.000 claims abstract 2
- 125000004104 aryloxy group Chemical group 0.000 claims abstract 2
- 125000002632 imidazolidinyl group Chemical group 0.000 claims abstract 2
- 229910052760 oxygen Inorganic materials 0.000 claims abstract 2
- 125000003072 pyrazolidinyl group Chemical group 0.000 claims abstract 2
- 125000001422 pyrrolinyl group Chemical group 0.000 claims abstract 2
- 229910052717 sulfur Inorganic materials 0.000 claims abstract 2
- 125000004306 triazinyl group Chemical group 0.000 claims abstract 2
- 125000001425 triazolyl group Chemical group 0.000 claims abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 8
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 7
- 238000006243 chemical reaction Methods 0.000 claims 7
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 6
- 150000003839 salts Chemical class 0.000 claims 6
- 239000002253 acid Substances 0.000 claims 5
- 239000002585 base Substances 0.000 claims 5
- 239000000543 intermediate Substances 0.000 claims 5
- 208000035143 Bacterial infection Diseases 0.000 claims 4
- 208000022362 bacterial infectious disease Diseases 0.000 claims 4
- 239000002904 solvent Substances 0.000 claims 4
- 125000004916 (C1-C6) alkylcarbonyl group Chemical group 0.000 claims 3
- 150000001204 N-oxides Chemical class 0.000 claims 3
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 3
- 125000004473 dialkylaminocarbonyl group Chemical group 0.000 claims 3
- 125000004438 haloalkoxy group Chemical group 0.000 claims 3
- 150000002431 hydrogen Chemical group 0.000 claims 3
- 125000002757 morpholinyl group Chemical group 0.000 claims 3
- 125000001624 naphthyl group Chemical group 0.000 claims 3
- 125000001712 tetrahydronaphthyl group Chemical group C1(CCCC2=CC=CC=C12)* 0.000 claims 3
- 241000894006 Bacteria Species 0.000 claims 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 claims 2
- 241000191967 Staphylococcus aureus Species 0.000 claims 2
- 239000003242 anti bacterial agent Substances 0.000 claims 2
- 125000002618 bicyclic heterocycle group Chemical group 0.000 claims 2
- 239000003054 catalyst Substances 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 208000015181 infectious disease Diseases 0.000 claims 2
- 231100000252 nontoxic Toxicity 0.000 claims 2
- 230000003000 nontoxic effect Effects 0.000 claims 2
- 238000002360 preparation method Methods 0.000 claims 2
- 150000003335 secondary amines Chemical class 0.000 claims 2
- 239000012453 solvate Substances 0.000 claims 2
- 125000006700 (C1-C6) alkylthio group Chemical group 0.000 claims 1
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 claims 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 claims 1
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 claims 1
- 201000005010 Streptococcus pneumonia Diseases 0.000 claims 1
- 241000193998 Streptococcus pneumoniae Species 0.000 claims 1
- 239000013543 active substance Substances 0.000 claims 1
- 239000003513 alkali Substances 0.000 claims 1
- 150000001412 amines Chemical group 0.000 claims 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 claims 1
- 125000004604 benzisothiazolyl group Chemical group S1N=C(C2=C1C=CC=C2)* 0.000 claims 1
- 125000004603 benzisoxazolyl group Chemical group O1N=C(C2=C1C=CC=C2)* 0.000 claims 1
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 claims 1
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 claims 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 claims 1
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000012458 free base Substances 0.000 claims 1
- 125000002541 furyl group Chemical group 0.000 claims 1
- 125000001041 indolyl group Chemical group 0.000 claims 1
- 125000001786 isothiazolyl group Chemical group 0.000 claims 1
- 125000000842 isoxazolyl group Chemical group 0.000 claims 1
- 239000003446 ligand Substances 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 1
- 229960003085 meticillin Drugs 0.000 claims 1
- 125000002950 monocyclic group Chemical group 0.000 claims 1
- 125000002911 monocyclic heterocycle group Chemical group 0.000 claims 1
- 125000002971 oxazolyl group Chemical group 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- UCQFSGCWHRTMGG-UHFFFAOYSA-N pyrazole-1-carboximidamide Chemical compound NC(=N)N1C=CC=N1 UCQFSGCWHRTMGG-UHFFFAOYSA-N 0.000 claims 1
- 125000002112 pyrrolidino group Chemical group [*]N1C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims 1
- 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 claims 1
- 125000000335 thiazolyl group Chemical group 0.000 claims 1
- 125000001544 thienyl group Chemical group 0.000 claims 1
- 230000009466 transformation Effects 0.000 claims 1
- 238000000844 transformation Methods 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06125545 | 2006-12-06 | ||
| PCT/EP2007/063319 WO2008068272A2 (en) | 2006-12-06 | 2007-12-04 | Antibacterial quinoline derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20110024T1 true HRP20110024T1 (hr) | 2011-04-30 |
Family
ID=38048032
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20110024T HRP20110024T1 (hr) | 2006-12-06 | 2011-01-13 | Antibakterijski derivati kvinolina |
Country Status (34)
| Country | Link |
|---|---|
| US (1) | US20100063026A1 (pl) |
| EP (1) | EP2099761B1 (pl) |
| JP (1) | JP5466013B2 (pl) |
| KR (1) | KR101553600B1 (pl) |
| CN (1) | CN101547906B (pl) |
| AP (1) | AP2477A (pl) |
| AR (1) | AR064148A1 (pl) |
| AT (1) | ATE486061T1 (pl) |
| AU (1) | AU2007328892B2 (pl) |
| BR (1) | BRPI0719915A2 (pl) |
| CA (1) | CA2668558C (pl) |
| CL (1) | CL2007003518A1 (pl) |
| CY (1) | CY1112027T1 (pl) |
| DE (1) | DE602007010182D1 (pl) |
| DK (1) | DK2099761T3 (pl) |
| EA (1) | EA016760B1 (pl) |
| ES (1) | ES2354755T3 (pl) |
| HK (1) | HK1137437A1 (pl) |
| HR (1) | HRP20110024T1 (pl) |
| IL (1) | IL199082A (pl) |
| JO (1) | JO2683B1 (pl) |
| ME (1) | ME01230B (pl) |
| MX (1) | MX2009005906A (pl) |
| MY (1) | MY145940A (pl) |
| NO (1) | NO341984B1 (pl) |
| NZ (1) | NZ576862A (pl) |
| PL (1) | PL2099761T3 (pl) |
| PT (1) | PT2099761E (pl) |
| RS (1) | RS51582B (pl) |
| SI (1) | SI2099761T1 (pl) |
| TW (1) | TWI487526B (pl) |
| UA (1) | UA101307C2 (pl) |
| WO (1) | WO2008068272A2 (pl) |
| ZA (1) | ZA200903949B (pl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JO2970B1 (en) * | 2006-12-06 | 2016-03-15 | جانسين فارماسوتيكا ان. في | Quinoline antibacterial derivatives |
| US9617244B2 (en) | 2012-04-27 | 2017-04-11 | Janssen Pharmaceutica Nv | Antibacterial quinoline derivatives |
| AU2013254674B2 (en) * | 2012-04-27 | 2017-02-02 | Janssen Pharmaceutica Nv | Antibacterial quinoline derivatives |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001503411A (ja) * | 1996-10-28 | 2001-03-13 | ディパートメント オブ ジ アーミー，ユー．エス．ガバメント | 抗生物質耐性感染症の処置のための化合物、組成物および方法 |
| EP1527050B1 (en) * | 2002-07-25 | 2010-04-07 | Janssen Pharmaceutica N.V. | Quinoline derivatives and their use as mycobacterial inhibitors |
| CN1909907B (zh) * | 2004-01-23 | 2010-06-23 | 詹森药业有限公司 | 喹啉衍生物及其在制备分枝杆菌抑制剂中的用途 |
| KR101160183B1 (ko) * | 2004-01-29 | 2012-06-26 | 얀센 파마슈티카 엔.브이. | 마이코박테리아 저해제로서 사용하기 위한 퀴놀린 유도체 |
| KR20130024969A (ko) * | 2004-05-28 | 2013-03-08 | 얀센 파마슈티카 엔.브이. | 약물 내성 마이코박테리아 질환 치료를 위한 치환된 퀴놀린 유도체의 용도 |
| EE05394B1 (et) * | 2004-12-24 | 2011-04-15 | Janssen Pharmaceutica N.V. | Kinoliinihendid kasutamiseks latentse tuberkuloosi ravis |
| EE05697B1 (et) * | 2005-06-08 | 2014-02-17 | Janssen Pharmaceutica N.V. | Kinoliini derivaadid kui antibakteriaalsed toimeained |
| JO2752B1 (en) * | 2005-06-28 | 2014-03-15 | شركة جانسين فارماسوتيكا ان. في | Quinoline derivatives acting as antibacterial agents |
| UA88701C2 (ru) * | 2005-06-28 | 2009-11-10 | Янссэн Фармацэвтика Н.В. | Производные хинолина как антибактериальные агенты |
| JO2855B1 (en) * | 2005-08-03 | 2015-03-15 | شركة جانسين فارماسوتيكا ان. في | Quinoline derivatives acting as antibacterial agents |
| JO2837B1 (en) * | 2005-08-03 | 2014-09-15 | جانسن فارمسيتكا ان في | Quinoline derivatives acting as antibacterial agents |
| JO2952B1 (en) * | 2005-08-03 | 2016-03-15 | جانسين فارماسوتيكا ان. في | Quinoline derivatives acting as antibacterial agents |
-
2007
- 2007-12-02 JO JO2007510A patent/JO2683B1/en active
- 2007-12-04 DE DE602007010182T patent/DE602007010182D1/de active Active
- 2007-12-04 RS RS20110019A patent/RS51582B/en unknown
- 2007-12-04 PL PL07847817T patent/PL2099761T3/pl unknown
- 2007-12-04 US US12/516,420 patent/US20100063026A1/en not_active Abandoned
- 2007-12-04 NZ NZ576862A patent/NZ576862A/en unknown
- 2007-12-04 MX MX2009005906A patent/MX2009005906A/es active IP Right Grant
- 2007-12-04 PT PT07847817T patent/PT2099761E/pt unknown
- 2007-12-04 KR KR1020097013568A patent/KR101553600B1/ko active IP Right Review Request
- 2007-12-04 SI SI200730471T patent/SI2099761T1/sl unknown
- 2007-12-04 EA EA200970537A patent/EA016760B1/ru unknown
- 2007-12-04 ES ES07847817T patent/ES2354755T3/es active Active
- 2007-12-04 AT AT07847817T patent/ATE486061T1/de active
- 2007-12-04 JP JP2009539742A patent/JP5466013B2/ja active Active
- 2007-12-04 ME MEP-2011-10A patent/ME01230B/me unknown
- 2007-12-04 AP AP2009004873A patent/AP2477A/xx active
- 2007-12-04 EP EP07847817A patent/EP2099761B1/en active Active
- 2007-12-04 UA UAA200904443A patent/UA101307C2/ru unknown
- 2007-12-04 WO PCT/EP2007/063319 patent/WO2008068272A2/en active Application Filing
- 2007-12-04 CN CN200780045128.8A patent/CN101547906B/zh active Active
- 2007-12-04 MY MYPI20092287A patent/MY145940A/en unknown
- 2007-12-04 DK DK07847817.9T patent/DK2099761T3/da active
- 2007-12-04 AU AU2007328892A patent/AU2007328892B2/en active Active
- 2007-12-04 CA CA2668558A patent/CA2668558C/en active Active
- 2007-12-04 BR BRPI0719915-5A2A patent/BRPI0719915A2/pt not_active Application Discontinuation
- 2007-12-05 CL CL200703518A patent/CL2007003518A1/es unknown
- 2007-12-05 AR ARP070105441A patent/AR064148A1/es unknown
- 2007-12-05 TW TW096146212A patent/TWI487526B/zh active
-
2009
- 2009-06-02 IL IL199082A patent/IL199082A/en active IP Right Grant
- 2009-06-05 ZA ZA200903949A patent/ZA200903949B/xx unknown
- 2009-07-06 NO NO20092541A patent/NO341984B1/no unknown
-
2010
- 2010-02-03 HK HK10101151.1A patent/HK1137437A1/xx unknown
-
2011
- 2011-01-13 HR HR20110024T patent/HRP20110024T1/hr unknown
- 2011-01-27 CY CY20111100087T patent/CY1112027T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20160585T1 (hr) | Antibakterijski derivati kinolina | |
| HRP20100428T1 (hr) | Antibakterijski derivati kvinolina | |
| JP2010511668A5 (pl) | ||
| JP2010511667A5 (pl) | ||
| US20230039712A1 (en) | Phenylaminopyrimidine amide autophagy inhibitors and methods of use thereof | |
| AU2012301953B2 (en) | Antibacterial compounds and methods for use | |
| HRP20110540T1 (hr) | Antibakterijski derivati kinolina | |
| HRP20131116T1 (hr) | Derivati kinolina kao antibakterijska sredstva | |
| US20050209210A1 (en) | Rifamycin imino derivatives effective against drug-resistant microbes | |
| HRP20110428T1 (hr) | Derivati piperidin-amino-benzimidazola kao inhibitori respiratorne sincitijalne virusne replikacije | |
| AU3122799A (en) | Amino compound | |
| EP2750505A1 (en) | Antibacterial compounds and methods for use | |
| MY159560A (en) | Quinoline derivatives as antibacterial agents | |
| HRP20090439T1 (hr) | Supstituirani derivati propenil piperazina kao novi inhibitori histonske deacetilaze | |
| HRP20110024T1 (hr) | Antibakterijski derivati kvinolina | |
| HRP20120910T1 (hr) | Derivati kinolina kao antibakterijska sredstva | |
| MXPA05007671A (es) | Derivados de triazina como absorbedores de uv. | |
| HRP20170044T1 (hr) | Derivati kinolina kao antibakterijska sredstva | |
| JPH03133960A (ja) | キノロンカルボン酸誘導体、それらを調製する方法および抗ウイルス剤としてのそれらの使用 | |
| JP2010511671A5 (pl) | ||
| HRP20090050T3 (en) | Novel pyrrolidine-3,4-dicarboxamide derivatives | |
| HRP20120912T1 (hr) | Derivati kinolina kao antibakterijska sredstva | |
| HRP20100384T1 (hr) | Antibakterijski derivati kvinolina | |
| IL268967B (en) | Azetidine derivative | |
| JP2010511670A5 (pl) |